Hints and tips:
Related Special Reports
...The best means to protect America’s economic future is not a broad retreat from globalisation....
A foray into US dealmaking four decades ago raised the hackles of locals and proved financially disappointing
...Whether the acquisition is approved or blocked by US authorities for national security reasons, Nippon Steel’s current dilemma has significant implications for Japan Inc as companies pursue growth outside...
...In September 2019, Roivant sold five of its most promising subsidiaries to Japan’s Sumitomo Dainippon Pharma in a blockbuster $3bn deal....
...Some pharma companies disputed the annual cost figures published by the health department....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...Legal hammer Oil supermajor ExxonMobil’s case against two climate activist groups has grabbed the attention of corporate America, the FT reports....
...If you have the long pharma/short junk food pair trade on, email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
...Mizuho, Mitsubishi UFJ Financial Group and Sumitomo Mitsui Financial Group are among the pilgrims....
...Its headcount in the Americas has doubled since 2010 to just over 3,000....
...In Amgen’s case, the FTC argued that the Big Pharma group could get buyers to favour Horizon’s drugs by bundling them with its own best medicines....
...Mizuho said Greenhill would sit within its existing banking division and be led by Michal Katz, its current head of banking in the Americas....
...Finding and assessing prospects in the pharma market takes time, according to Denton, an experienced dealmaker who when working as chief financial officer at pharmacy giant CVS in 2018 oversaw its $68bn...
...“Humira is the most valuable biologic drug ever and AbbVie is known as one of the most aggressive pharma companies ever....
...Her public protests against members of the Sackler family, whose company Purdue Pharma produced the addictive OxyContin drug, are the backbone of the acclaimed film All the Beauty and the Bloodshed (2022...
...Instead of warning investors about risky investment in America’s most valuable company, the SEC warns investors about weak disclosures by Chinese companies....
...Iain Simpson, analyst at Barclays, said that following the ruling “we regard Zantac as substantially derisked, leaving Haleon investible again for those without the appetite for pharma litigation risk”....
...“People were thinking that I’m trying to go into the pharma business [as] window dressing for my tobacco business,” he says. He is accustomed to receiving a frosty reception from scientists....
...Disappointing results might also act as a catalyst for a shift in funding for Alzheimer’s research, with some scientists arguing that promising areas of study and potential treatments have been crowded out by Big Pharma...
...It also sold $2.3bn of shares in the second quarter, cutting its stakes in General Motors, US Bancorp and grocer Kroger, and exited its positions in Verizon and Royalty Pharma....
...A version of this article was first published by Nikkei Asia on October 27 2022. ©2022 Nikkei Inc. All rights reserved....
...Dainippon Pharma....
...In comparison, sales at the pharma division grew 8 per cent to $45bn last year....
...The company already has drug candidates in clinical trials, two psychiatric treatments in partnership with Japanese drugmaker Sumitomo Dainippon Pharma, and another in oncology, which it is developing itself...
International Edition